Allopregnanolone and neuroinflammation: A focus on multiple sclerosis

Frontiers in Cellular Neuroscience

Volumn 8, Issue JUN, 2014, Pages

  Noorbakhsh, Farshid ^a   Baker, Glen B ^b   Power, Christopher ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Allopregnanolone; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroinflammation; Neurosteroid

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; DEMYELINATION; GENE EXPRESSION; HUMAN; LYMPHOCYTE; MULTIPLE SCLEROSIS; MYELINATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW;

EID: 84901982119     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00134     Document Type: Review

References (68)

1. Abourbeh, G., Theze, B., Maroy, R., Dubois, A., Brulon, V., Fontyn, Y., et al. (2012). Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714. J. Neurosci. 32, 5728-5736. doi: 10.1523/JNEUROSCI.2900-11.201232/17/5728
2. Adeosun, S. O., Hou, X., Jiao, Y., Zheng, B., Henry, S., Hill, R., et al. (2012). Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease. PLoS ONE 7:e50040. doi: 10.1371/journal.pone.0050040PONE-D-12-18290
3. Arnason, B. G., and Richman, D. P. (1969a). Effects of estrogen, progestin and combined estrogen-progestin oral contraceptive preparations on experimental allergic encephalomyelitis. Trans. Am. Neurol. Assoc. 94, 54-58.
4. Arnason, B. G., and Richman, D. P. (1969b). Effect of oral contraceptives on experimental demyelinating disease. Arch. Neurol. 21, 103-108. doi: 10.1001/archneur.1969.00480130117012
5. Baulieu, E. E., and Schumacher, M. (1997). Neurosteroids, with special reference to the effect of progesterone on myelination in peripheral nerves. Mult. Scler. 3, 105-112. doi: 10.1177/135245859700300209
6. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 6, 565-575. doi: 10.1038/nrn1703
7. Bhat, R., Axtell, R., Mitra, A., Miranda, M., Lock, C., Tsien, R. W., et al. (2010). Inhibitory role for GABA in autoimmune inflammation. Proc. Natl. Acad. Sci. U.S.A. 107, 2580-2585. doi: 10.1073/pnas.0915139107
8. Brinton, R. D. (2013). Neurosteroids as regenerative agents in the brain: therapeutic implications. Nat. Rev. Endocrinol. 9, 241-250. doi: 10.1038/nrendo.2013.31nrendo.2013.31
9. Charalampopoulos, I., Alexaki, V. I., Tsatsanis, C., Minas, V., Dermitzaki, E., Lasaridis, I., et al. (2006). Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Ann. N. Y. Acad. Sci. 1088, 139-152. doi: 10.1196/annals.1366.003
10. Charalampopoulos, I., Remboutsika, E., Margioris, A. N., and Gravanis, A. (2008). Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab. 19, 300-307. doi: 10.1016/j.tem.2008.07.004
11. Correale, J., Arias, M., and Gilmore, W. (1998). Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 161, 3365-3374.
12. Daugherty, D. J., Selvaraj, V., Chechneva, O. V., Liu, X. B., Pleasure, D. E., and Deng, W. (2013). A TSPO ligand is protective in a mouse model of multiple sclerosis. EMBO Mol. Med. 5, 891-903. doi: 10.1002/emmm.201202124
13. Djebaili, M., Guo, Q., Pettus, E. H., Hoffman, S. W., and Stein, D. G. (2005). The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma 22, 106-118. doi: 10.1089/neu.2005.22.106
14. El-Etr, M., Vukusic, S., Gignoux, L., Durand-Dubief, F., Achiti, I., Baulieu, E. E., et al. (2005). Steroid hormones in multiple sclerosis. J. Neurol. Sci. 233, 49-54. doi: 10.1016/j.jns.2005.03.004
15. Garay, L., Deniselle, M. C., Lima, A., Roig, P., and De Nicola, A. F. (2007). Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid Biochem. Mol. Biol. 107, 228-237. doi: 10.1016/j.jsbmb.2007.03.040
16. Gatliff, J., and Campanella, M. (2012). The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr. Mol. Med. 12, 356-368. doi: 10.2174/1566524011207040356
17. Ghezzi, P., Santo, E. D., Sacco, S., Foddi, C., Barbaccia, M. L., and Mennini, T. (2000). Neurosteroid levels are increased in vivo after LPS treatment and negatively regulate LPS-induced TNF production. Eur. Cytokine Netw. 11, 464-469.
18. Ghoumari, A. M., Baulieu, E. E., and Schumacher, M. (2005). Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 135, 47-58. doi: 10.1016/j.neuroscience.2005.05.023
19. Ghoumari, A. M., Ibanez, C., El-Etr, M., Leclerc, P., Eychenne, B., O'Malley, B. W., et al. (2003). Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86, 848-859. doi: 10.1046/j.1471-4159.2003.01881.x
20. Girard, C., Liu, S., Adams, D., Lacroix, C., Sineus, M., Boucher, C., et al. (2012). Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J. Neuroendocrinol. 24, 71-81. doi: 10.1111/j.1365-2826.2011.02215.x
21. Griffin, L. D., Gong, W., Verot, L., and Mellon, S. H. (2004). Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat. Med. 10, 704-711. doi: 10.1038/nm1073nm1073
22. He, J., Evans, C. O., Hoffman, S. W., Oyesiku, N. M., and Stein, D. G. (2004). Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp. Neurol. 189, 404-412. doi: 10.1016/j.expneurol.2004.06.008
23. Hemmer, B., Archelos, J. J., and Hartung, H. P. (2002). New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3, 291-301. doi: 10.1038/nrn784nrn784
24. Irwin, R. W., and Brinton, R. D. (2014). Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise. Prog. Neurobiol. 113, 40-55. doi: 10.1016/j.pneurobio.2013.08.004
25. Ishrat, T., Sayeed, I., Atif, F., Hua, F., and Stein, D. G. (2010). Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp. Neurol. 226, 183-190. doi: 10.1016/j.expneurol.2010.08.023
26. Jack, C., Ruffini, F., Bar-Or, A., and Antel, J. P. (2005). Microglia and multiple sclerosis. J. Neurosci. Res. 81, 363-373. doi: 10.1002/jnr.20482
27. Kipp, M., and Beyer, C. (2009). Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front. Neuroendocrinol. 30, 188-200. doi: 10.1016/j.yfrne.2009.04.004
28. Lavisse, S., Guillermier, M., Herard, A. S., Petit, F., Delahaye, M., Van Camp, N., et al. (2012). Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J. Neurosci. 32, 10809-10818. doi: 10.1523/JNEUROSCI.1487-12.201232/32/10809
29. Leaver, K. R., Reynolds, A., Bodard, S., Guilloteau, D., Chalon, S., and Kassiou, M. (2012). Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum. ACS Chem. Neurosci. 3, 114-119. doi: 10.1021/cn200099e
30. Lee, M., Schwab, C., and McGeer, P. L. (2011). Astrocytes are GABAergic cells that modulate microglial activity. Glia 59, 152-165. doi: 10.1002/glia.21087
31. Leskiewicz, M., Budziszewska, B., Basta-Kaim, A., Zajac, A., Kacinski, M., and Lason, W. (2006). Effects of neurosteroids on neuronal survival: molecular basis and clinical perspectives. Acta Neurobiol. Exp. (Wars), 66, 359-367.
32. Mares, P., Kubova, H., and Kasal, A. (2010). Anticonvulsant action of a new analogue of allopregnanolone in immature rats. Physiol. Res. 59, 305-308.
33. Mares, P., Mikulecka, A., Haugvicova, R., and Kasal, A. (2006). Anticonvulsant action of allopregnanolone in immature rats. Epilepsy Res. 70, 110-117. doi: 10.1016/j.eplepsyres.2006.03.009
34. Mayo, L., Quintana, F. J., and Weiner, H. L. (2012). The innate immune system in demyelinating disease. Immunol. Rev. 248, 170-187. doi: 10.1111/j.1600-065X.2012.01135.x
35. Mead, E. L., Mosley, A., Eaton, S., Dobson, L., Heales, S. J., and Pocock, J. M. (2012). Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions. J. Neurochem. 121, 287-301. doi: 10.1111/j.1471-4159.2012.07659.x
36. Melcangi, R. C., Magnaghi, V., Cavarretta, I., Zucchi, I., Bovolin, P., D'Urso, D., et al. (1999). Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J. Neurosci. Res. 56, 349-357. doi: 10.1002/(SICI)1097-4547(19990515)56:4%3C349::AID-JNR3%3E3.3.CO;2-8
37. Mellon, S. H., and Griffin, L. D. (2002). Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13, 35-43. doi: 10.1016/S1043-2760(01)00503-3
38. Mendu, S. K., Bhandage, A., Jin, Z., and Birnir, B. (2012). Different subtypes of GABA-A receptors are expressed in human, mouse and rat T lymphocytes. PLoS ONE 7:e42959. doi: 10.1371/journal.pone.0042959PONE-D-12-03109
39. Morali, G., Montes, P., Hernandez-Morales, L., Monfil, T., Espinosa-Garcia, C., and Cervantes, M. (2011). Neuroprotective effects of progesterone and allopregnanolone on long-term cognitive outcome after global cerebral ischemia. Restor. Neurol. Neurosci. 29, 1-15. doi: 10.3233/RNN-2011-0571
40. Moscarello, M. A., Mastronardi, F. G., and Wood, D. D. (2007). The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem. Res. 32, 251-256. doi: 10.1007/s11064-006-9144-5
41. Muller, E., and Kerschbaum, H. H. (2006). Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuro Endocrinol. Lett. 27, 675-678.
42. Nohria, V., and Giller, E. (2007). Ganaxolone. Neurotherapeutics 4, 102-105. doi: 10.1016/j.nurt.2006.11.003
43. Noorbakhsh, F., Ellestad, K. K., Maingat, F., Warren, K. G., Han, M. H., Steinman, L., et al. (2011). Impaired neurosteroid synthesis in multiple sclerosis. Brain 134(Pt 9), 2703-2721. doi: 10.1093/brain/awr200awr200
44. Nothdurfter, C., Rammes, G., Baghai, T. C., Schule, C., Schumacher, M., Papadopoulos, V., et al. (2012). Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. J. Neuroendocrinol. 24, 82-92. doi: 10.1111/j.1365-2826.2011.02166.x
45. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapere, J. J., Lindemann, P., et al. (2006). Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409. doi: 10.1016/j.tips.2006.06.005
46. Paul, A. M., Branton, W. G., Walsh, J. G., Polyak, M. J., Lu, J. Q., Baker, G. B., et al. (2014). GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone. Neuroscience. doi: 10.1016/j.neuroscience.2014.04.037. [Epub ahead of print].
47. Paul, S. M., and Purdy, R. H. (1992). Neuroactive steroids. FASEB J. 6, 2311-2322.
48. Pieribone, V. A., Tsai, J., Soufflet, C., Rey, E., Shaw, K., Giller, E., et al. (2007). Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy. Epilepsia 48, 1870-1874. doi: 10.1111/j.1528-1167.2007.01182.x
49. Prineas, J. W., and Parratt, J. D. (2012). Oligodendrocytes and the early multiple sclerosis lesion. Ann. Neurol. 72, 18-31. doi: 10.1002/ana.23634
50. Reyes-Garcia, M. G., Hernandez-Hernandez, F., Hernandez-Tellez, B., and Garcia-Tamayo, F. (2007). GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production. J. Neuroimmunol. 188, 64-68. doi: 10.1016/j.jneuroim.2007.05.013
51. Rone, M. B., Fan, J., and Papadopoulos, V. (2009). Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim. Biophys. Acta 1791, 646-658. doi: 10.1016/j.bbalip.2009.03.001
52. Sayeed, I., Guo, Q., Hoffman, S. W., and Stein, D. G. (2006). Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann. Emerg. Med. 47, 381-389. doi: 10.1016/j.annemergmed.2005.12.011
53. Shuster, E. A. (2008). Hormonal influences in multiple sclerosis. Curr. Top. Microbiol. Immunol. 318, 267-311. doi: 10.1007/978-3-540-73677-6_11
54. Simpkins, J. W., Yang, S. H., Wen, Y., and Singh, M. (2005). Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell. Mol. Life Sci. 62, 271-280. doi: 10.1007/s00018-004-4382-2
55. Singh, C., Liu, L., Wang, J. M., Irwin, R. W., Yao, J., Chen, S., et al. (2012). Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice. Neurobiol. Aging 33, 1493-1506. doi: 10.1016/j.neurobiolaging.2011.06.008
56. Singh, S., Hota, D., Prakash, A., Khanduja, K. L., Arora, S. K., and Chakrabarti, A. (2010). Allopregnanolone, the active metabolite of progesterone protects against neuronal damage in picrotoxin-induced seizure model in mice. Pharmacol. Biochem. Behav. 94, 416-422. doi: 10.1016/j.pbb.2009.10.003
57. Sospedra, M., and Martin, R. (2005). Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747. doi: 10.1146/annurev.immunol.23.021704.115707
58. Stys, P. K., Zamponi, G. W., van Minnen, J., and Geurts, J. J. (2012). Will the real multiple sclerosis please stand up? Nat. Rev. Neurosci. 13, 507-514. doi: 10.1038/nrn3275nrn3275
59. Tian, J., Chau, C., Hales, T. G., and Kaufman, D. L. (1999). GABA(A) receptors mediate inhibition of T cell responses. J. Neuroimmunol. 96, 21-28.
60. Timby, E., Balgard, M., Nyberg, S., Spigset, O., Andersson, A., Porankiewicz-Asplund, J., et al. (2006). Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl.), 186, 414-424. doi: 10.1007/s00213-005-0148-7
61. Trapp, B. D., and Nave, K. A. (2008). Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247-269. doi: 10.1146/annurev.neuro.30.051606.094313
62. Tsutsui, S., Noorbakhsh, F., Sullivan, A., Henderson, A. J., Warren, K., Toney-Earley, K., et al. (2005). RON-regulated innate immunity is protective in an animal model of multiple sclerosis. Ann. Neurol. 57, 883-895. doi: 10.1002/ana.20502
63. van Broekhoven, F., Backstrom, T., van Luijtelaar, G., Buitelaar, J. K., Smits, P., and Verkes, R. J. (2007). Effects of allopregnanolone on sedation in men, and in women on oral contraceptives. Psychoneuroendocrinology 32, 555-564. doi: 10.1016/j.psyneuen.2007.03.009
64. VanLandingham, J. W., Cekic, M., Cutler, S., Hoffman, S. W., and Stein, D. G. (2007). Neurosteroids reduce inflammation after TBI through CD55 induction. Neurosci. Lett. 425, 94-98. doi: 10.1016/j.neulet.2007.08.045
65. Venneti, S., Lopresti, B. J., and Wiley, C. A. (2006). The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog. Neurobiol. 80, 308-322. doi: 10.1016/j.pneurobio.2006.10.002
66. Wang, J. M., Johnston, P. B., Ball, B. G., and Brinton, R. D. (2005). The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 25, 4706-4718. doi: 10.1523/JNEUROSCI.4520-04.2005
67. Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., et al. (2010). Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 107, 6498-6503. doi: 10.1073/pnas.1001422107
68. Zhao, Y. Y., Yu, J. Z., Li, Q. Y., Ma, C. G., Lu, C. Z., and Xiao, B. G. (2011). TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation. Neuron Glia Biol. 7, 187-197. doi: 10.1017/S1740925X12000129